pone.0290879.s003.pdf (532.99 kB)
Excess of cases estimates with 95% CIs for GBS cases corresponding to exposures with RIs estimated in the 42 days risk period with p<0.05.
journal contribution
posted on 2024-01-19, 18:43 authored by Cristina Morciano, Stefania Spila Alegiani, Francesca Menniti Ippolito, Valeria Belleudi, Gianluca Trifirò, Giovanna Zanoni, Aurora Puccini, Ester Sapigni, Nadia Mores, Olivia Leoni, Giuseppe Monaco, Elena Clagnan, Cristina Zappetti, Emanuela Bovo, Maria Cutillo, Roberto Da Cas, Marco MassariExcess of cases estimates with 95% CIs for GBS cases corresponding to exposures with RIs estimated in the 42 days risk period with p<0.05.
History
Usage metrics
Categories
Keywords
marketing active surveillanceelasomeran ), bnt162b2dependent exposure usingaged &# 880588 &# 821156 &# 821137 &# 821135 &# 821130 september 202108 &# 8211regional health caretozinameran ), chadox1least one dosexlink "> mrnasubgroup analysis due38 &# 821114 &# 8211increased risk among19 vaccine chadox1gbs outpatient casessyndrome following covidincreased riskemergency carerisk resultedgbs casesexcess cases19 vaccinationsecond dosedose comparedvaccination registriesstudy investigatedsmall numberrelative incidencerecord linkagelow numbergbs outcomegbs howevergbs ).estimated selfdatabase self77 ).60 years12 years
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC